Clinical Trial Update: Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nelotanserin for visual hallucinations in Lewy body dementia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lewy Body Dementia
• Visual Hallucinations

Drugs mentioned

• nelotanserin (nelotanserin)

Snippet

Sponsor: Axovant Sciences Ltd. | Conditions: Lewy Body Dementia, Visual Hallucinations | Phase 2 | Status: COMPLETED